| Literature DB >> 25177700 |
Ender Hür1, Melih Özişik2, Cihan Ural2, Gürsel Yildiz3, Kemal Mağden1, Sennur Budak Köse4, Füruzan Köktürk5, Çağatay Büyükuysal5, Ibrahim Yildirim1, Gültekin Süleymanlar6, Kenan Ateş7, Soner Duman2.
Abstract
OBJECTIVES: Hypertension and hypervolemia relationship was proven among renal disease, although it is not known in normal population. Present study determines the fluid distribution defects in relation to blood pressure.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25177700 PMCID: PMC4142663 DOI: 10.1155/2014/895401
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Characteristics of the study population (n = 2034).
|
| |
|---|---|
| Gender | |
| Male | 1456 (71.6) |
| Female | 578 (28.4) |
| Age groups | |
| <65 | 1870 (91.9) |
| ≥65 | 164 (8.1) |
| Geographical region | |
| Central Anatolia | 323 (15.9) |
| Mediterranean | 141 (6.9) |
| Aegean | 578 (28.4) |
| East Anatolia | 626 (30.8) |
| Southeastern Anatolia | 366 (18) |
| Measurement time | |
| Morning (<12 o'clock) | 649 (31.9) |
| Afternoon (≥12 o'clock) | 1385 (68.1) |
| Disease history | |
| Healthy | 1250 (61.5) |
| Diabetics | 240 (11.8) |
| Known HT | 380 (18.7) |
| CAD | 87 (4.3) |
| COPD | 41 (2) |
| CKD | 47 (2.9) |
| Anti-HT | |
| ACEi/ARB | 96 (4.7) |
| Beta blockers | 50 (2.5) |
| CCB | 18 (0.9) |
| Diuretics | 7 (0.3) |
The number of subjects is crude (unadjusted) figures.
HT: hypertension, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, CKD: chronic kidney disease, ACEi: angiotensin converting enzyme inhibitors, ARB: angiotensin receptor blockers, and CCB: calcium channel blockers.
Univariate analysis of systolic blood pressure categories.
| Variables | Hypotensives | Normotensives | Hypertensives |
|---|---|---|---|
| BMI (kg/m²) | 26.38 ± 4.98 | 27.59 ± 4.39 a | 29.49 ± 4.23 a∗ b∗ |
| ECW/height (L/m) | 9.93 ± 1.58 | 10.34 ± 1.32 a∗ | 10.78 ± 1.32 a∗ b∗ |
| Age | 41.47 ± 11.69 | 44.36 ± 12.38 a | 52.84 ± 11.23 a∗ b∗ |
| DM | 0.06 ± 0.24 | 0.09 ± 0.28 | 0.18 ± 0.39 a∗ b∗ |
| Smoking | 0.16 ± 0.37 | 0.16 ± 0.37 | 0.11 ± 0.31 b |
| FTI (kg/m²) | 10.46 ± 5.12 | 11.22 ± 5.26 | 13.23 ± 5.14 a∗ b∗ |
| BSA (m²) | 1.82 ± 0.19 | 1.88 ± 0.17 a∗ | 1.91 ± 0.16 a∗ b∗ |
| TBW (L) | 38.10 ± 7.14 | 39.88 ± 6.56 a | 40.29 ± 6.64 a∗ |
| OH (L) | 0.09 ± 1.09 | 0.03 ± 1.01 | 0.07 ± 1.11 |
P < 0.05; a: group versus hypotensives; b: group versus normotensives; *P < 0.001.
SBP: systolic blood pressure, BMI: body mass index, ECW: extracellular water, DM: diabetes mellitus, FTI: fat tissue index, BSA: body surface area, TBW: total body water, and OH: overhydration.
Logistic regression analysis for “high systolic blood pressure.”
| Variables | Odds ratio | 95% CI |
|
|---|---|---|---|
| DM | 1.581 | 1.177–2.124 | 0.002 |
| ECW/height | 1.104 | 1.003–1.215 | 0.043 |
| BMI | 1.058 | 1.027–1.090 | 0.000 |
| Age | 1.053 | 1.043–1.063 | 0.000 |
DM: diabetes mellitus, ECW: extracellular water, BMI: body mass index, and CI: confidence interval. In model: OH/ECW, E/I, TBW, ECW/height, age, gender, BMI, LTI, FTI, DM, time, and smoking.
Figure 1Obesity related with hydration fat tissue index and systolic blood pressure. P < 0.001 between all groups. ECW: extracellular water/height (L/m2), FTI: fat tissue index (kg/m2), SBP: systolic blood pressure (mmHg), and BMI: body mass index (kg/m2).
Figure 2Diabetes mellitus related to hydration fat tissue index and systolic blood pressure. P < 0.001 between all groups. ECW: extracellular water/height (L/m2), FTI: fat tissue index (kg/m2), SBP: systolic blood pressure (mmHg), and BMI: body mass index (kg/m2).
Figure 3Smoking related to hydration fat tissue index and systolic blood pressure. P < 0.001 for FTI and SBP. ECW: extracellular water/height (L/m2), FTI: fat tissue index (kg/m2), SBP: systolic blood pressure (mmHg), and BMI: body mass index (kg/m2).
Figure 4Hydration reference plot.
Comorbidities according to hydration reference plot.
| Hydration reference plot regions | BMI (median) | DM (%) | CAD (%) | CKD (%) |
|---|---|---|---|---|
| 1 ( | 30 (24.8–36.5) | 33.3 a | 0 a∗ | 9.1 |
| 2 ( | 29.7 (18.1–41.6) a∗ | 20.3 a∗ | 7.7 a∗ | 4.6 |
| 3 ( | 28.6 (18.3–50.6) a∗ | 6.71 | 2.4 | 0 |
| 4 ( | 26.9 (17.5–36.9) | 18.2 | 13.6 a∗ | 0 |
| DX ( | 27.5 (15.8–45.5) | 9.7 | 3.4 | 2.7 |
|
| ||||
| Total (2034) | 28 (15.8–50.6) | 11.8 | 4.3 | 2.9 |
P < 0.05; a: group versus DX. *P < 0.001.
BMI: body mass index, CAD: coronary artery disease, CKD: chronic kidney disease, and DX: overhydration between −1.1 and 2.5 L with systolic blood pressure 100–150 mmHg.